EGFR

You have access
Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction
KENICHI ARATANI, SHUHEI KOMATSU, DAISUKE ICHIKAWA, TAKUMA OHASHI, MAHITO MIYAMAE, WATARU OKAJIMA, TAISUKE IMAMURA, JUN KIUCHI, KEIJI NISHIBEPPU, TOSHIYUKI KOSUGA, HIROTAKA KONISHI, ATSUSHI SHIOZAKI, HITOSHI FUJIWARA, KAZUMA OKAMOTO, HITOSHI TSUDA and EIGO OTSUJI

Anticancer Research June 2017, 37 (6) 3129-3135;
You have access
Up-regulation of SLC9A9 Promotes Cancer Progression and Is Involved in Poor Prognosis in Colorectal Cancer
MASAMI UEDA, TOMOHIRO IGUCHI, TAKAAKI MASUDA, HISATERU KOMATSU, SHO NAMBARA, SHOTARO SAKIMURA, HIDENARI HIRATA, RYUTARO UCHI, HIDETOSHI EGUCHI, SHUHEI ITO, KEISHI SUGIMACHI, TSUNEKAZU MIZUSHIMA, YUICHIRO DOKI, MASAKI MORI and KOSHI MIMORI

Anticancer Research May 2017, 37 (5) 2255-2263;
You have access
Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer
DIMITRIOS PECTASIDES, VASILIKI KOTOULA, GEORGE PAPAXOINIS, ZOI ALEXOPOULOU, CHRISTOS DERVENIS, EPAMINONTAS SAMANTAS, KLEO PAPAPARASKEVA, ELPIDA CHARALAMBOUS, CHRYSOULA GKAKOU, CHRISTOS AGALIANOS, KONSTANTINE T. KALOGERAS, GEORGE PENTHEROUDAKIS and GEORGE FOUNTZILAS

Anticancer Research December 2016, 36 (12) 6347-6356;
You have access
In Silico Identification of Novel Erlotinib Analogues Against Epidermal Growth Factor Receptor
ISHFAQ A. SHEIKH and HANI MUTLAK A. HASSAN

Anticancer Research November 2016, 36 (11) 6125-6132;
You have access
Targeted Therapies in HPV-positive and -negative HNSCC – Alteration of EGFR and VEGFR-2 Expression In Vitro
BENEDIKT KRAMER, CLEMENS HOCK, RICHARD BIRK, ALEXANDER SAUTER, BORIS A. STUCK, KARL HÖRMANN, JOHANNES DAVID SCHULTZ and CHRISTOPH ADERHOLD

Anticancer Research June 2016, 36 (6) 2799-2807;
You have access
Phase II Trial of Erlotinib in Elderly Patients with Previously Treated Non-small Cell Lung Cancer: Results of the Lung Oncology Group in Kyushu (LOGiK-0802)
KAZUHIKO YAMADA, KOICHI AZUMA, MASAFUMI TAKESHITA, JUNJI UCHINO, CHINATSU NISHIDA, TAKAYUKI SUETSUGU, AKIRA KONDO, TAISHI HARADA, HIROFUMI EIDA, JUNJI KISHIMOTO, GOKI ERIGUCHI, KOICHI TAKAYAMA, YOICHI NAKANISHI and KENJI SUGIO

Anticancer Research June 2016, 36 (6) 2881-2887;
You have access
Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer
SOTIRIOS LAKIS, STEFANOS DIMOUDIS, VASSILIKI KOTOULA, ZOI ALEXOPOULOU, IOANNIS KOSTOPOULOS, TRIANTAFYLLIA KOLETSA, MATTHEOS BOBOS, ELENI TIMOTHEADOU, IRENE PAPASPIROU, IOANNIS EFSTRATIOU, GERASIMOS ARAVANTINOS, VASILIOS KARAVASILIS, FLORA ZAGOURI, HELEN GOGAS, EVANGELIA RAZIS, GEORGE PENTHEROUDAKIS, CHRISTOS CHRISTODOULOU, DIMITRIOS PECTASIDES and GEORGE FOUNTZILAS

Anticancer Research May 2016, 36 (5) 2365-2378;
You have access
Establishment and Characterization of a Pair of Patient-derived Human Non-small Cell Lung Cancer Cell Lines from a Primary Tumor and Corresponding Lymph Node Metastasis
FLORIAN GEBAUER, DANIEL WICKLEIN, MICHAEL TACHEZY, TOBIAS GROB, DORIS STEINEMANN, GEORGI MANUKJAN, GUDRUN GÖHRING, BRIGITTE SCHLEGELBERGER, HANNA MAAR, JAKOB R. IZBICKI, MAXIMILIAN BOCKHORN and UDO SCHUMACHER

Anticancer Research April 2016, 36 (4) 1507-1518;
You have access
A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling
GUIFANG DU, CHENGCHENG HAO, YANAN GU, ZHIYAN WANG, WEN G. JIANG, JUNQI HE and SHAN CHENG

Anticancer Research March 2016, 36 (3) 1165-1173;
You have access
Proton Irradiation Sensitizes Radioresistant Non-small Cell Lung Cancer Cells by Modulating Epidermal Growth Factor Receptor-mediated DNA Repair
HYUNG JU PARK, JEONG SU OH, JONG WOOK CHANG, SANG-GU HWANG and JAE-SUNG KIM

Anticancer Research January 2016, 36 (1) 205-212;

Main menu

User menu

Search

EGFR

Pages